Physician
Urology
Dr. Sima P. Porten, MD
|
|
Give Review
Sima Porten is an expert in the field of Urology. He over the years received 1 awards: "Fellow (FACS)". Doctor Sima P. Porten, MD is a published doctor. He has 29 papers published. The most current publication "Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes." Sima Porten accepts Medicare payments and is listed with Medicare.gov.
Publications
- Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes.
- Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.
- Updated trends in imaging use in men diagnosed with Prostate cancer.
- Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
- Identification of distinct Basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
- Refining Patient Selection for Neoadjuvant Chemotherapy Prior to Radical Cystectomy.
- Myths and Mysteries Surrounding Bacillus Calmette-Guérin Therapy for Bladder Cancer.
- Gunshot wounds to the lower urinary tract: A single-institution experience.
- The role of active surveillance in the management of Prostate cancer.
- Active surveillance: Does serial Prostate biopsy increase histological inflammation?
- High-risk nonmuscle invasive bladder cancer: definition and epidemiology.
- Changes in cancer volume in serial biopsies of men on active surveillance for early stage Prostate cancer.
- Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance.
- The outcomes of perineal urethrostomy with preservation of the dorsal urethral plate and urethral blood supply.
- The relationship between Prostate specific antigen change and biopsy progression in patients on active surveillance for Prostate cancer.
- Factors associated with downgrading in patients with high grade Prostate cancer.
- The example of CaPSURE: lessons learned from a national disease registry.
- Outcomes of active surveillance for men with intermediate-risk Prostate cancer.
- Disproportionate presentation of high risk Prostate cancer in a safety net health system.
- Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.
- The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formers.
- Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis.
- Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
- Xanthogranulomatous pyelonephritis presenting with a left flank mass.
- Prevalence and severity of undiagnosed urinary incontinence in women.
- The independent value of tumour volume in a contemporary cohort of men treated with radical Prostatectomy for clinically localized disease.
- Diagnosis of female diverticula using magnetic resonance imaging.
- Prostate cancer: reducing overtreatment: active surveillance in low-risk disease.
Schools
NWU FIENBERG SCH OF MED
Conditions Treated
- Enlarged Prostate (BPH)
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (FACS)
Education
-
UCSF
Drug Facts
| NPI NUMBER | 1124157474 | |
| NPPES Provider LastName | PORTEN | |
| NPPES Provider FirstName | SIMA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 146.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 35.0 | |
| Percent Opioid Claims | 23.97 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124157474 |
| Last Name Of The Provider | PORTEN |
| First Name Of The Provider | SIMA |
| View All |
Similar Doctors
|
Dr. Mark D. Kalish, MD |
|
Dr. Steven E. Canfield, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Wright, MD |
|
|
Dr. James M. Harris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alvin C. Goh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monty Aghazadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. Cook, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan J. Melquist, MD |
|
|
Dr. Gavin N. Wagenheim, MD |